Univariable and multivariable analysis were used to explore the factors affecting DFS and OS for EGFR-mutated stage IA patients, adjusting for age, sex, smoking history, tumor laterality, resection type, T stage, TPM group, predominant subtype, and EGFR mutation status (Table 3). The gene discussed is EGFR; the disease is neoplasm.